FOXA2
Overview
FOXA2 (forkhead box A2, also known as HNF3B) is a pioneer transcription factor with established roles in proximal tubule and renal development. In the context of ccRCC initiation, FOXA2 is identified as a mediator of HIF2A-specific transcriptional output following VHL loss in proximal tubule cells.
Alterations observed in the corpus
- Identified by LISA and ChEA3 (top 50 in both analyses) as a transcription factor whose binding sites are enriched at HIF2A-specific (but not HIF1A-specific) Vhl-dependent gene loci in a murine ccRCC precursor model; proposed to mediate HIF2A’s tissue-restricted, dedifferentiation-linked transcriptional output PMID:23797736
- Recurrent FOXA2 mutations were enriched in mCRPC tumors with neuroendocrine features (small-cell histology) across 63 men profiled at rapid autopsy PMID:26928463
Cancer types (linked)
- CCRCC — FOXA2 binding-site enrichment at EPAS1/HIF2A-specific targets after VHL loss links this developmental TF to the dedifferentiation program in ccRCC precursor cells PMID:23797736
Co-occurrence and mutual exclusivity
- Co-identified with HNF4A and HNF1B as TFs mediating EPAS1/HIF2A-specific transcription downstream of VHL loss PMID:23797736
Therapeutic relevance
- FOXA2 mediates the HIF2A-driven dedifferentiation program that is therapeutically targeted by belzutifan in VHL disease PMID:23797736
Open questions
- Whether FOXA2 is directly required for ccRCC tumor initiation or is a cooperative factor has not been tested by genetic perturbation in this model PMID:23797736
Sources
This page was processed by crosslinker on 2026-05-09. - PMID:26928463
This page was processed by wiki-cli on 2026-05-14.